PROCEEDINGS VOLUME 10047
SPIE BIOS | JAN 28 - FEB 2 2017
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVI
Proceedings Volume 10047 is from: Logo
SPIE BIOS
Jan 28 - Feb 2 2017
San Francisco, California, United States
Front Matter: Volume 10047
Proc. SPIE 10047, Front Matter: Volume 10047, 1004701 (12 April 2017); doi: 10.1117/12.2269858
Photodynamic Therapy I
Proc. SPIE 10047, Sequential vs. simultaneous photokilling by mitochondrial and lysosomal photodamage, 1004702 (8 February 2017); doi: 10.1117/12.2251207
Proc. SPIE 10047, Repurposing molecules: old dogs new tricks (Conference Presentation), 1004703 (); doi: 10.1117/12.2257430
Proc. SPIE 10047, Aminolevulinic acid-mediated protoporphyrin IX and photodynamic therapy for breast cancers (Conference Presentation), 1004704 (); doi: 10.1117/12.2253509
Photodynamic Therapy II
Proc. SPIE 10047, PDT-based combinations in overcoming chemoresistance from stromal and heterotypic cellular communication (Conference Presentation), 1004705 (); doi: 10.1117/12.2252685
Proc. SPIE 10047, In vivo wide-field multispectral dosimeter for use in ALA-PpIX based photodynamic therapy of skin, 1004707 (8 February 2017); doi: 10.1117/12.2252402
Proc. SPIE 10047, Local pressure and matrix component effects on verteporfin distribution in pancreatic tumors (Conference Presentation), 1004708 (); doi: 10.1117/12.2249766
Photodynamic Therapy III
Proc. SPIE 10047, A summary of light dose distribution using an IR navigation system for Photofrin-mediated Pleural PDT, 1004709 (21 February 2017); doi: 10.1117/12.2253027
Proc. SPIE 10047, Oxygen measurements to improve singlet oxygen dosimetry, 100470A (13 February 2017); doi: 10.1117/12.2250432
Proc. SPIE 10047, The exploitation of inflammation in photodynamic therapy of pleural cancer (Conference Presentation), 100470B (); doi: 10.1117/12.2253316
Proc. SPIE 10047, Monitoring and assessment of tumor hemodynamics during pleural PDT, 100470C (16 February 2017); doi: 10.1117/12.2252979
Proc. SPIE 10047, Phototoxic effects of free phthalocyanine and phthalocyanine conjugated to gold nanoparticles for targeted photodynamic therapy of melanoma cancer, 100470D (8 February 2017); doi: 10.1117/12.2252682
Photodynamic Therapy IV
Proc. SPIE 10047, Nanoscale metal-organic frameworks for photodynamic therapy and cancer immunotherapy (Conference Presentation), 100470F (); doi: 10.1117/12.2261217
Proc. SPIE 10047, A compact diode laser based all-fiber delivery system for PDT+PTT with integrated temperature sensing capabilities, 100470G (8 February 2017); doi: 10.1117/12.2254796
Photodynamic Therapy V
Proc. SPIE 10047, Minimally toxic approach for treatment of cutaneous breast cancer metastases: capecitabine-enhanced photodynamic therapy, 100470K (8 February 2017); doi: 10.1117/12.2256511
Photodynamic Therapy VI
Proc. SPIE 10047, Real time laser speckle imaging monitoring vascular targeted photodynamic therapy, 100470M (8 February 2017); doi: 10.1117/12.2251971
Proc. SPIE 10047, Intraoperative photodynamic treatment for high-grade gliomas, 100470N (8 February 2017); doi: 10.1117/12.2251351
Proc. SPIE 10047, Invasion-promoting extracellular matrix composition enhances photodynamic therapy response in 3D pancreatic cancer models , 100470O (8 February 2017); doi: 10.1117/12.2252983
Photodynamic Therapy VII
Proc. SPIE 10047, Multimodal OCT for assessment of vasculature-targeted PDT success, 100470Q (8 February 2017); doi: 10.1117/12.2251914
Proc. SPIE 10047, Overview of computational simulations for PDT treatments based on optimal choice of singlet oxygen, 100470R (8 February 2017); doi: 10.1117/12.2252552
Proc. SPIE 10047, Simple and optimum background-free estimation method of PPIX fluorescence for 5-ALA-based fluorescence diagnosis of malignant lesions, 100470S (8 February 2017); doi: 10.1117/12.2250780
Photodynamic Therapy VIII
Proc. SPIE 10047, Threshold dose distribution and its causes and consequences in photodynamic therapy (Conference Presentation), 100470T (); doi: 10.1117/12.2250640
Proc. SPIE 10047, Novel trace norm regularization method for fluorescence molecular tomography reconstruction, 100470U (8 February 2017); doi: 10.1117/12.2251688
Proc. SPIE 10047, Real-time monitoring the distribution of antibody-photo-absorber conjugates during photoimmunotherapy in vivo (Conference Presentation), 100470V (); doi: 10.1117/12.2253355
Poster Session
Proc. SPIE 10047, Singlet oxygen explicit dosimetry to predict long-term local tumor control for BPD-mediated photodynamic therapy, 100470X (13 February 2017); doi: 10.1117/12.2250435
Proc. SPIE 10047, 3-compartment dynamic model of talaporfin sodium pharmacokinetics in silico, 100470Y (8 February 2017); doi: 10.1117/12.2250716
Proc. SPIE 10047, Singlet oxygen explicit dosimetry to predict local tumor control for HPPH-mediated photodynamic therapy, 1004710 (8 February 2017); doi: 10.1117/12.2251011
Proc. SPIE 10047, Singlet oxygen explicit dosimetry to predict long-term local tumor control for Photofrin-mediated photodynamic therapy, 1004711 (8 February 2017); doi: 10.1117/12.2251015
Proc. SPIE 10047, The relevance of light diffusion profiles for interstitial PDT using light-diffusing optical fibers, 1004712 (8 February 2017); doi: 10.1117/12.2252170
Proc. SPIE 10047, Target-specific porphyrin-loaded hybrid nanoparticles to improve photodynamic therapy for cancer treatment, 1004713 (8 February 2017); doi: 10.1117/12.2252618
Proc. SPIE 10047, Photodynamic therapy in neurosurgery: a proof of concept of treatment planning system, 1004714 (8 February 2017); doi: 10.1117/12.2252622
Proc. SPIE 10047, Phototodynamic activity of zinc monocarboxyphenoxy phthalocyane (ZnMCPPc) conjugated to gold silver (AuAg) nanoparticles in melanoma cancer cells, 1004716 (8 February 2017); doi: 10.1117/12.2252838
Proc. SPIE 10047, Four-channel PDT dose dosimetry for pleural photodynamic therapy, 1004717 (8 February 2017); doi: 10.1117/12.2253055
Proc. SPIE 10047, Temperature mapping and thermal dose calculation in combined radiation therapy and 13.56 MHz radiofrequency hyperthermia for tumor treatment, 1004718 (8 February 2017); doi: 10.1117/12.2253163
Back to Top